5-132390140-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003060.4(SLC22A5):​c.1053-550G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.776 in 187,624 control chromosomes in the GnomAD database, including 58,070 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.76 ( 45834 hom., cov: 33)
Exomes 𝑓: 0.83 ( 12236 hom. )

Consequence

SLC22A5
NM_003060.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.567

Publications

15 publications found
Variant links:
Genes affected
SLC22A5 (HGNC:10969): (solute carrier family 22 member 5) Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. The encoded protein is a plasma integral membrane protein which functions both as an organic cation transporter and as a sodium-dependent high affinity carnitine transporter. The encoded protein is involved in the active cellular uptake of carnitine. Mutations in this gene are the cause of systemic primary carnitine deficiency (CDSP), an autosomal recessive disorder manifested early in life by hypoketotic hypoglycemia and acute metabolic decompensation, and later in life by skeletal myopathy or cardiomyopathy. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2015]
SLC22A5 Gene-Disease associations (from GenCC):
  • systemic primary carnitine deficiency disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, G2P, Orphanet, PanelApp Australia, Labcorp Genetics (formerly Invitae), Myriad Women’s Health
  • short QT syndrome
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.889 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC22A5NM_003060.4 linkc.1053-550G>C intron_variant Intron 6 of 9 ENST00000245407.8 NP_003051.1 O76082-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC22A5ENST00000245407.8 linkc.1053-550G>C intron_variant Intron 6 of 9 1 NM_003060.4 ENSP00000245407.3 O76082-1

Frequencies

GnomAD3 genomes
AF:
0.765
AC:
116243
AN:
152038
Hom.:
45828
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.551
Gnomad AMI
AF:
0.861
Gnomad AMR
AF:
0.814
Gnomad ASJ
AF:
0.873
Gnomad EAS
AF:
0.910
Gnomad SAS
AF:
0.833
Gnomad FIN
AF:
0.869
Gnomad MID
AF:
0.715
Gnomad NFE
AF:
0.844
Gnomad OTH
AF:
0.797
GnomAD4 exome
AF:
0.827
AC:
29318
AN:
35468
Hom.:
12236
Cov.:
0
AF XY:
0.826
AC XY:
15570
AN XY:
18850
show subpopulations
African (AFR)
AF:
0.507
AC:
311
AN:
614
American (AMR)
AF:
0.808
AC:
2774
AN:
3432
Ashkenazi Jewish (ASJ)
AF:
0.872
AC:
490
AN:
562
East Asian (EAS)
AF:
0.908
AC:
1915
AN:
2110
South Asian (SAS)
AF:
0.817
AC:
4059
AN:
4966
European-Finnish (FIN)
AF:
0.852
AC:
874
AN:
1026
Middle Eastern (MID)
AF:
0.767
AC:
69
AN:
90
European-Non Finnish (NFE)
AF:
0.831
AC:
17501
AN:
21052
Other (OTH)
AF:
0.820
AC:
1325
AN:
1616
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
236
472
708
944
1180
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
198
396
594
792
990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.764
AC:
116289
AN:
152156
Hom.:
45834
Cov.:
33
AF XY:
0.768
AC XY:
57115
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.551
AC:
22841
AN:
41476
American (AMR)
AF:
0.814
AC:
12456
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.873
AC:
3032
AN:
3472
East Asian (EAS)
AF:
0.910
AC:
4721
AN:
5186
South Asian (SAS)
AF:
0.833
AC:
4014
AN:
4818
European-Finnish (FIN)
AF:
0.869
AC:
9209
AN:
10596
Middle Eastern (MID)
AF:
0.707
AC:
208
AN:
294
European-Non Finnish (NFE)
AF:
0.844
AC:
57354
AN:
67994
Other (OTH)
AF:
0.790
AC:
1669
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1272
2544
3815
5087
6359
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
858
1716
2574
3432
4290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.793
Hom.:
5758
Bravo
AF:
0.753
Asia WGS
AF:
0.809
AC:
2811
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
2.9
DANN
Benign
0.41
PhyloP100
0.57
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs274553; hg19: chr5-131725832; API